Microbot Medical
Financiado
SCS a self cleaning shunt for the continuous prevention of shunt blockage in h...
SCS a self cleaning shunt for the continuous prevention of shunt blockage in hydrocephalus and NPH patients
"Microbot Medical is an award-winning start up in the medical device field that was lounched in 2010 by an expert team with extensive experience in clinical practice, mechanical engineering, electronics and business development. A...
"Microbot Medical is an award-winning start up in the medical device field that was lounched in 2010 by an expert team with extensive experience in clinical practice, mechanical engineering, electronics and business development. Althouogh based in Israel, we have been building our international projection since inception, developing a first of its kind, innovative and disruptive ropotic shunt that will be able to improve the quality of life of millions of patients globally by advancing micro-robotics technologies to perform surgical procedures within the human body, and offer physicians and their patients less invasive and more precise solutions.
Hydrocephalus, also known as ""water in the brain"" is a medical condition in which there an abnormal accumulation of cerebrospinal fluid in the ventricles of the brain. An estimated 750,000 people are living with it in the US alone, with similar numbers in Europe. It causes increased intracranial pressure inside the skill and progressive enlargement of the head, convulsion, tunnel vision, and mental disability, as well as death. It is the only common form of dementia that is reversible.
Treatment is done by implanting shunts, used to drain excess fluids from patients brain, but are needed to be replaced regularly in surgery.
Microbot Medical's SCS will help lower the number of surgeries done annually around the world, estimated at over 40,000 in the US alone (once every 15 minutes) – with similar number in the EU, with a total cost of over $2B."
ver más
Duración del proyecto: 5 meses
Fecha Inicio: 2018-05-31
Fecha Fin: 2018-11-30
Fecha Fin: 2018-11-30
Línea de financiación: concedida
El organismo H2020 notifico la concesión del proyecto el día 2018-11-30
Línea de financiación objetivo
El proyecto se financió a través de la siguiente ayuda:
EIC-SMEInst-2018-2020:
SME instrument
Cerrada
hace 6 años
Presupuesto
El presupuesto total del proyecto asciende a
71K€
Líder del proyecto
MICROBOT MEDICAL LTD
No se ha especificado una descripción o un objeto social para esta compañía.
Perfil tecnológico
TRL
4-5
Perfil tecnológico
TRL
4-5
295.54K€ |
Participante